Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Chartmill

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Genpact (NYSE:G) Slips After Inline Q2 Results ↗
Via Chartmill
Tickers G
CareTrust REIT (NYSE:CTRE) Beats Q2 Estimates and Raises Full-Year Guidance ↗
Via Chartmill
Tickers CTRE
Corvus Pharmaceuticals (NASDAQ:CRVS) Misses Q2 Loss Estimates as Clinical-Stage Spending Continues ↗
Via Chartmill
Tickers CRVS
Concentra (NYSE:CON) Beats Q2 Estimates and Raises Guidance, but Shares Stay Flat ↗
Via Chartmill
Tickers CON
Celldex Therapeutics (NASDAQ:CLDX) Q2 EPS Beat Overshadowed by Revenue Miss and Prurigo Nodularis Discontinuation ↗
Via Chartmill
Tickers CLDX
Consensus Cloud Solution (NASDAQ:CCSI) Tumbles on Weak Outlook Despite In-Line Q2 ↗
Via Chartmill
Tickers CCSI
Amphastar Pharmaceuticals (NASDAQ:AMPH) Beats Q2 Earnings Estimates, Shares Rise After Hours ↗
Via Chartmill
Tickers AMPH
AMN Healthcare (NYSE:AMN) Surges After Blowout Q2 Earnings Beat ↗
Via Chartmill
Tickers AMN
American International Group (NYSE:AIG) Beats Q2 Earnings, But Revenue Misses ↗
Via Chartmill
Tickers AIG
Senseonics Holdings (NASDAQ:SENS) Jumps on Q2 Revenue Beat and Raised Full-Year Guidance ↗
Via Chartmill
Tickers SENS
ResMed (NYSE:RMD) Q4 Results Inline with Estimates; Stock Slips 1.9% ↗
Via Chartmill
Tickers ASX:RMD RMD
Ouster (NASDAQ:OUST) Drops on Soft Q3 Guidance Despite Q2 Beat ↗
Via Chartmill
Tickers OUST
Octave Specialty Group (NYSE:OSG) Revenue Beats but Adjusted Loss Widens in Q2 ↗
Via Chartmill
Tickers OSG
Omada Health (NASDAQ:OMDA) Soars on Q2 Beat, Record Margins, and Raised Guidance ↗
Via Chartmill
Tickers OMDA
Nerdy (NYSE:NRDY) Slides After Q2 Report as Weak Guidance Overshadows Results ↗
Via Chartmill
Tickers NRDY
Northern Oil and Gas (NYSE:NOG) Beats Q2 Estimates but Stock Tepid on Operational Disruptions and Hedging Costs ↗
Via Chartmill
Tickers NOG
Nelnet (NYSE:NNI) Shares Rise Despite Q2 EPS Miss ↗
Via Chartmill
Tickers NNI
Discover the top S&P500 movers in Thursday's after-hours session. ↗
Via Chartmill
Tickers ABNB AKAM COHR MCHP
Manitowoc (NYSE:MTW) Beats Q2 Estimates, Raises Full-Year Guidance ↗
Via Chartmill
Tickers MTW
Monster Beverage (NASDAQ:MNST) Slips After Inline Q2 EPS ↗
Via Chartmill
Tickers MNST
AEYE (NASDAQ:LIDR) Q2 Revenue Misses Estimates but Commercial Pipeline Reaches Record ↗
Via Chartmill
Tickers LIDR
INmune Bio (NASDAQ:INMB) Beats Q2 Loss Estimates but Shares Tumble on Business Update ↗
Via Chartmill
Tickers INMB
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Via Chartmill
Tickers BAER CPOP CRSR CVRX DOCS DSY
ICF International (NASDAQ:ICFI) Reports Mixed Q2 as Earnings Beat, Revenue Miss ↗
Via Chartmill
Topics Earnings
Tickers ICFI
Health Catalyst (NASDAQ:HCAT) Tumbles 24% on Weak Guidance Despite Q2 Earnings Beat ↗
Via Chartmill
Tickers HCAT
Expensify (NASDAQ:EXFY) Shares Surge After Q2 Earnings Beat as New Platform Momentum Accelerates ↗
Via Chartmill
Topics Earnings
Tickers EXFY
Doximity (NYSE:DOCS) Surges on AI Engagement Momentum Despite EPS Miss and Soft Guidance ↗
Via Chartmill
Topics Artificial Intelligence
Tickers DOCS
Denali Therapeutics (NASDAQ:DNLI) Drops as Q2 AVLAYAH Revenue Misses Estimates ↗
Via Chartmill
Tickers DNLI
Definium Therapeutics (NASDAQ:DFTX) Slides After Q2 Loss Misses Estimates on Warrant Charge ↗
Via Chartmill
Tickers DFTX
Cytokinetics (NASDAQ:CYTK) Beats Q2 Estimates on Strong MYQORZO Launch ↗
Via Chartmill
Tickers CYTK
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.